Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 9.50M | $ 12.60M | $ 14.10M | $ 0.00 | $ 187.20M |
Total Assets | $ 348.00M | $ 379.90M | $ 398.70M | $ 425.10M | $ 454.50M |
Total Debt | $ 77.50M | $ 95.90M | $ 70.00M | $ 44.10M | $ 68.50M |
Net Debt | $ 68.00M | $ 83.30M | $ 55.90M | $ 44.10M | $ -118.70M |
Total Liabilities | $ 137.50M | $ 178.20M | $ 193.30M | $ 210.50M | $ 225.00M |
Stockholders Equity | $ 210.50M | $ 201.70M | $ 205.40M | $ 214.60M | $ 229.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |